Joanne K Taylor; Neil Pendleton
The selected studies collated results from 916 patients with HIV/AIDS, end-stage renal failure, chronic obstructive pulmonary disease (COPD) and geriatric cachexia. The authors conclude that current evidence does not support the use of progesterone therapies for non-cancer cachexia. There may however be a limited role for its use as an appetite stimulant in a palliative context on a case-by-case basis.
Full text available in BMJ Supportive and Palliative Care
Available in print in Arthur Rank Hospice, Cambridge